Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Chitosan-encapsulated Cordyceps militaris reduces lung cell damage from pollution.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Cardiomyocyte-derived media can inhibit lung cancer cell growth and movement.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

Erlotinib can cause excessive eyelash growth.

Astragaloside A may help fight lung cancer by targeting specific proteins.

Metabolic syndrome may increase the risk of small cell lung cancer.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.

A chest X-ray can effectively diagnose ectopic ACTH secretion from lung tumors.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Grape seed extract may safely and effectively help prevent lung cancer.

Natural products may help treat Non-Small Cell Lung Cancer by causing cancer cell death through ferroptosis.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

The treatment combination is effective and generally safe for lung cancer.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Blocking certain receptors in the lungs might help treat a specific type of asthma.

New compounds effective against SARS-CoV-2 variants were identified using a rapid testing method with human lung cells.

Minoxidil does not work to inhibit lysyl hydroxylases in newborn mouse lungs.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Anti-angiogenic drugs do not worsen COVID-19 severity in lung cancer patients.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

The document lists research on Pemetrexed and Cisplatin for lung cancer but doesn't give a final conclusion.